Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 31
Filter
1.
J Drugs Dermatol ; 21(9): SF3502915-SF35029114, 2022 Sep 01.
Article in English | MEDLINE | ID: mdl-36074515

ABSTRACT

BACKGROUND: Dysregulation of either the cutaneous microbiome (CM) or epidermal barrier function (EBF) is thought to play an increasingly important role in acne vulgaris (AV) and rosacea pathogenesis. OBJECTIVE: To review the literature regarding epidermal barrier dysfunction (EBD) and cutaneous dysbiosis in AV and rosacea and provide clinical pearls for dermatologists. METHODS: A Medline literature search was performed for relevant literature regarding EBD and dysbiosis and either AV or rosacea. An expert consensus panel was then convened to discuss article merits and distill findings into clinical pearls. RESULTS: Final review included 138 articles. Puberty may alter natural stratum corneum lipid ratios, instigating and/or exacerbating EBD in AV. Patients with severe AV have an abundance of virulent Cutibacterium acnes phylotype IA1. EBD may manifest as classic signs of rosacea and improve with treatment. While several microbial populations are dysregulated in rosacea, the effect from any singular species is unclear. Current AV and rosacea treatment regimens may mitigate inflammation but may also indiscriminately damage CM and EBF. Physiologic moisturizers and cleansers that harness pre-/pro-/postbiotics may have a role in restoring CM, EBF, and potentially improving dermatosis severity. LIMITATIONS: Limited prospective clinical trial data especially regarding over-the-counter (OTC)/non-prescription skincare products. CONCLUSION: Appropriately developed prescription and OTC preparations may selectively influence the microbiome and potentially maintain/restore EBF. By understanding this relationship, dermatologists will be better able to educate patients on the importance of appropriate skin care.J Drugs Dermatol. 2022;21:9(Suppl 2):s5-14.


Subject(s)
Acne Vulgaris , Microbiota , Rosacea , Acne Vulgaris/drug therapy , Acne Vulgaris/therapy , Dysbiosis , Humans , Prospective Studies , Rosacea/drug therapy , Rosacea/therapy
2.
J Drugs Dermatol ; 19(10): 935-940, 2020 Oct 01.
Article in English | MEDLINE | ID: mdl-33026777

ABSTRACT

BACKGROUND: Atopic dermatitis (AD) is a common skin condition characterized by disturbed barrier function, skin inflammation, and cutaneous dysbiosis. Clinically, it manifests as chronic-recurrent xerosis, pruritus, and erythematous lesions. Its pathophysiology is complex, making the selection of appropriate treatment options a task. AIM: To share insights gained from a literature review and discussions with experts in dermatology on key factors related to the prevention, treatment, and management of AD in relation to the skin microbiome. METHODS: Results from an expert panel were summarized and discussed to provide updated recommendations for the treatment and maintenance of AD. RESULTS: Evidence supports a strategy for managing inflammatory skin diseases with a selenium-rich post-biotic thermal water and biomass containing moisturizer. The moisturizer helps to restore homeostasis of the skin, re-populate a diverse microbiome, encourage the growth of commensal bacteria, and improve barrier function and symptoms of AD. CONCLUSIONS: Normalization of skin microbiome diversity using a topical moisturizer containing post-biotic aqua and biomass may offer a valuable option for the treatment and maintenance of inflammatory skin diseases. Clinicians should discuss the benefits of this treatment in the context of a full AD management program that covers prevention, active treatment, and maintenance. J Drugs Dermatol. 2020;19(10):935-940. doi:10.36849/JDD.2020.5393.


Subject(s)
Dermatitis, Atopic/therapy , Dermatologic Agents/administration & dosage , Hydrotherapy/methods , Microbiota/immunology , Skin/microbiology , Administration, Cutaneous , Adult , Child, Preschool , Combined Modality Therapy/methods , Combined Modality Therapy/standards , Dermatitis, Atopic/complications , Dermatitis, Atopic/immunology , Dermatitis, Atopic/microbiology , Dermatology/methods , Dermatology/standards , Drug Therapy, Combination/methods , Drug Therapy, Combination/standards , Humans , Infant , Practice Guidelines as Topic , Prebiotics/administration & dosage , Probiotics/administration & dosage , Severity of Illness Index , Skin/drug effects , Skin/immunology , Symbiosis/immunology , Treatment Outcome , Water Loss, Insensible/drug effects , Water Loss, Insensible/immunology
3.
Am J Dermatopathol ; 38(12): 904-909, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27831941

ABSTRACT

Lupus erythematosus panniculitis, also known as lupus profundus, is a variant in the clinicopathological spectrum of lupus erythematosus (LE) affecting about 2%-3% of LE patients. A linear configuration of LE panniculitis has been reported rarely with rare reports describing the coexistence of different forms of cutaneous LE and localized morphea. In this study, the authors present a 9-year-old girl with linear arrangement of subcutaneous nodules on her left forearm. Microscopic findings from 2 biopsies included lymphocytes at the dermoepidermal junction with mild interface dermatitis, a dense lymphocytic infiltrate that was concentrated around adnexae and subcutaneous fat in concert with thickened collagen bundles and mild widening of fibrous septae surrounding fat lobules. Although the clinical differential diagnosis included panniculitis or a sporotrichoid infection, 1 biopsy showed a dense lymphocytic infiltrate histologically bordered on that of cutaneous lymphoid hyperplasia or a late stage of Lyme disease, and a second also demonstrated more prominent sclerodermoid collagen bundles rendering the diagnosis of linear sclerodermoid LE profundus.


Subject(s)
Adipose Tissue/pathology , Panniculitis, Lupus Erythematosus/pathology , Scleroderma, Localized/pathology , Skin/pathology , Adipose Tissue/drug effects , Adipose Tissue/immunology , Biopsy , Child , Female , Forearm , Humans , Immunohistochemistry , Immunosuppressive Agents/therapeutic use , Lymphocytes/pathology , Panniculitis, Lupus Erythematosus/drug therapy , Panniculitis, Lupus Erythematosus/immunology , Remission Induction , Scleroderma, Localized/drug therapy , Scleroderma, Localized/immunology , Skin/drug effects , Skin/immunology , Treatment Outcome
4.
Pediatr Dermatol ; 32(6): e267-72, 2015.
Article in English | MEDLINE | ID: mdl-26446288

ABSTRACT

We present two cases of infants with a similar constellation of clinical findings: retro-orbital infantile hemangioma (IH), internal carotid artery (ICA) arteriopathy, and intracranial IH. In both cases, intracranial vascular anomalies and hemangiomas were found incidentally during evaluation of unilateral proptosis. Neither infant had evidence of cutaneous segmental IH of the face or neck, which might have provided a clue to the diagnosis of PHACE syndrome or of intracranial hemangiomas. In one case, intracranial involvement was particularly extensive and function threatening, with mass effect on the brain parenchyma. These cases serve to highlight the fact that clinical findings of proptosis, globe deviation, and strabismus should prompt immediate imaging to confirm the presence of orbital IHs and to exclude other diagnoses. Moreover, based on our cases and the embryologic origin of the orbit as a unique developmental unit, patients with confirmed retro-orbital IHs should undergo evaluation for anomalies associated with PHACE syndrome. Patients with orbital IHs and an additional major criterion for PHACE syndrome should be considered to have definite, and not just possible, PHACE syndrome.


Subject(s)
Aortic Coarctation/diagnosis , Eye Abnormalities/diagnosis , Hemangioma/diagnosis , Neurocutaneous Syndromes/diagnosis , Orbital Neoplasms/diagnosis , Aortic Coarctation/drug therapy , Carotid Artery, Internal/pathology , Diagnosis, Differential , Eye Abnormalities/drug therapy , Female , Hemangioma/drug therapy , Humans , Infant , Magnetic Resonance Imaging , Neurocutaneous Syndromes/drug therapy , Orbital Neoplasms/drug therapy , Propranolol/therapeutic use , Vasodilator Agents/therapeutic use
5.
Pediatr Dermatol ; 31(1): 33-7, 2014.
Article in English | MEDLINE | ID: mdl-24224977

ABSTRACT

Recessive dystrophic epidermolysis bullosa (RDEB) is a genetic disorder in which mutations in collagen VII, the main component of the anchoring fibril, lead to skin fragility and to the development of acute and chronic wounds. Wound care and dressing changes are an important part of the daily lives of individuals with RDEB. Ideal wound care should improve wound healing, minimize pain, and improve quality of life. The objective of the current study was to review wound care options that might be used in a patient with RDEB and calculate the cost of these various options based on publicly available pricing of wound care products. There is a wide range of costs for wound care options in patients with RDEB. For example, a 1-day supply of dressing for a neonate boy with RDEB ranges from $10.64 for the least expensive option to $127.54 for the most expensive option. Wound care in patients with severe, generalized RDEB has not only a significant economic effect, but also directly affects quality of life in this patient population. Although randomized controlled trials evaluating different wound care products in patients with RDEB are lacking, small studies and expert opinion support the use of specialized nonadherent dressings that minimize skin trauma and promote wound healing. Until there is a cure, prospective studies are needed to assess pain, quality of life, and wound healing associated with the use of specialized wound care products for this life-altering condition.


Subject(s)
Bandages/economics , Epidermolysis Bullosa Dystrophica/economics , Health Care Costs , Skin Care/economics , Wounds and Injuries/economics , Wounds and Injuries/therapy , Child , Child, Preschool , Collagen Type VII/genetics , Epidermolysis Bullosa Dystrophica/genetics , Female , Humans , Infant , Infant, Newborn , Male , Wound Healing
8.
J Am Acad Dermatol ; 69(6): 909-15, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24099729

ABSTRACT

BACKGROUND: Congenital erosive and vesicular dermatosis (CEVD) healing with reticulated supple scarring, a condition usually observed in premature neonates, presents at birth with vesicles and erosions. Lesions typically heal within a few months, leaving behind scarring with a distinctive supple and reticulated texture. OBJECTIVES: We sought to merge existing literature with new cases to further define CEVD. METHODS: We analyzed 19 previous reports of CEVD and added 9 additional patients; we identified unifying characteristics of this cohort. RESULTS: In 28 total cases, notable features included: preterm birth (79%), nail abnormalities (46%), hyperthermia/hypohidrosis (46%), a history of maternal chorioamnionitis (43%), alopecia (43%), neurodevelopmental and ophthalmologic abnormalities (36% each), tongue atrophy (29%), or a combination of these. Patients with CEVD may be prone to postnatal herpetic superinfections. Previously unreported findings included: erosive lichen planus, digital tip gangrene, and hydronephrosis. LIMITATIONS: The small patient sampling makes it difficult to define diagnostic criteria. As certain findings are associated with prematurity, it is unclear to what extent these features result from CEVD, premature birth, or another intrauterine pathology. CONCLUSIONS: Although rare, CEVD should be considered in the differential diagnosis of neonatal vesicles/erosions in the context of a negative infectious workup. This review strengthens the spectrum of CEVD features, thus facilitating its recognition by clinicians.


Subject(s)
Cicatrix/etiology , Skin Diseases, Vesiculobullous/congenital , Skin Diseases, Vesiculobullous/complications , Humans , Infant , Infant, Newborn
10.
J Pediatr Hematol Oncol ; 35(8): 618-22, 2013 Nov.
Article in English | MEDLINE | ID: mdl-23774156

ABSTRACT

Kasabach-Merritt phenomenon (KMP) is a rare consumptive coagulopathy characterized by profound thrombocytopenia and hypofibrinogenemia occurring in association with the vascular tumors kaposiform hemangioendothelioma (KHE) and tufted angioma (TA). Treatment remains challenging without consensus on the optimal medical management. The authors compiled expert opinions regarding management to establish treatment recommendations. Twenty-seven vascular anomalies centers in the United States and Canada were surveyed using 2 representative cases of KHE/TA with and without KMP. Overall response rate was 92% (25/27) with 88% completion (24/27). Most sites (23/25; 92%) do not have a standard of practice for management. The most frequent initial therapy for KHE+KMP was a combination of systemic corticosteroids and vincristine (VCR) (12/24 centers; 50%) followed by corticosteroids alone (29%). Second-line treatments were VCR (38%), rapamycin (21%), and propranolol (21%). Management of KHE/TA without KMP was variable; initial treatments included systemic corticosteroids (8/24; 33%) alone or with VCR (9/24; 38%), monitoring without medication (33%), VCR (8%), propranolol (8%), aspirin (4%), and rapamycin (4%). This survey highlights certain trends in the management of KMP-associated tumors, without standard protocols and consensus.


Subject(s)
Hemangioendothelioma/drug therapy , Hemangioma/drug therapy , Kasabach-Merritt Syndrome/drug therapy , Practice Patterns, Physicians'/statistics & numerical data , Sarcoma, Kaposi/drug therapy , Skin Neoplasms/drug therapy , Adrenal Cortex Hormones/therapeutic use , Antineoplastic Agents/therapeutic use , Data Collection , Hemangioendothelioma/etiology , Hemangioma/etiology , Humans , Kasabach-Merritt Syndrome/complications , Kasabach-Merritt Syndrome/etiology , Propranolol/therapeutic use , Sarcoma, Kaposi/etiology , Skin Neoplasms/etiology , Vasodilator Agents/therapeutic use , Vincristine/therapeutic use
11.
JAMA Dermatol ; 149(3): 283-91, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23553063

ABSTRACT

IMPORTANCE: Controversy exists regarding strategies for diagnosis and management of Spitz nevi, a type of melanocytic neoplasm that most often develops in children. OBJECTIVE: To determine the beliefs, behaviors, and experiences of pediatric dermatologists with regard to Spitz nevi. DESIGN: Anonymous web-based survey. SETTING: Private and academic dermatology practices. PARTICIPANTS: Respondents included 175 pediatric dermatologists from the United States and around the world, representing a 51.1% response rate (175 of 342). Analyses were limited to the 144 respondents whose practices included at least 50% children (younger than 18 years). MAIN OUTCOME MEASURES: Assessment of the following with regard to Spitz nevi: frequency of diagnosis, general beliefs, techniques used for evaluation (eg, dermoscopy and biopsy), management strategies, and observed outcomes. RESULTS: Collectively, respondents had seen approximately 20 000 Spitz nevi; 67.6% (96 of 142) had diagnosed at least 6 Spitz nevi yearly, whereas 90.1% (128 of 142) had diagnosed no more than 2 prepubertal melanomas in the past 5 years. Ninety-six percent of respondents (95.8%; 136 of 142) categorized typical Spitz nevi as benign. Eighty percent of respondents (79.6%; 113 of 142) used dermatoscopy, and 96.5% (137 of 142) avoided partial biopsies of Spitz nevi. In children with a suspected Spitz nevus, clinical follow-up was chosen by 49.3% (69 of 140) of respondents for a small, stable nonpigmented lesion and by 29.7% (41 of 138) for a pigmented lesion with a typical starburst pattern seen via dermatoscopy. Predictors of clinical follow-up of the latter lesion included believing that Spitz nevi are not melanoma precursors (P = .04). Forty-seven percent (62 of 132) of respondents had observed involution of Spitz nevi. No deaths had resulted from the approximately 10 000 Spitz nevi or atypical spitzoid neoplasms seen by the 91 respondents with academic or hospital-based practices. CONCLUSIONS AND RELEVANCE: The results of our survey support conservative management of Spitz nevi in children, with clinical follow-up representing an option for typical lesions. This represents an important difference from strategies used for management of these lesions in adults.


Subject(s)
Attitude of Health Personnel , Nevus, Epithelioid and Spindle Cell/therapy , Practice Patterns, Physicians'/statistics & numerical data , Skin Neoplasms/therapy , Adolescent , Child , Dermatology/statistics & numerical data , Health Care Surveys , Humans , Nevus, Epithelioid and Spindle Cell/diagnosis , Outcome Assessment, Health Care , Pediatrics/statistics & numerical data , Skin Neoplasms/diagnosis
12.
Sports Med ; 43(7): 575-89, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23456491

ABSTRACT

Each year in the United States over 80 million people participate in bat-and-ball sports, for example baseball and softball. Cricket, the world's second most popular sport, is enjoyed by hundreds of millions of participants in such countries as India, Pakistan, Australia, New Zealand, Bangladesh, South Africa, West Indies, Sri Lanka, United Kingdom, and Zimbabwe. Although any player can develop skin disease as a result of participation in these bat-and-ball sports, competitive team athletes are especially prone to skin problems related to infection, trauma, allergy, solar exposure, and other causes. These diseases can produce symptoms that hinder individual athletic performance and participation. In this review, we discuss the diagnosis and best-practice management of skin diseases that can develop as a result of participation in baseball, softball, and cricket.


Subject(s)
Baseball , Skin Diseases/etiology , Anabolic Agents/adverse effects , Androgens/adverse effects , Baseball/injuries , Contusions/diagnosis , Contusions/etiology , Contusions/therapy , Dermatitis, Contact/diagnosis , Dermatitis, Contact/etiology , Dermatitis, Contact/therapy , Drug Eruptions/diagnosis , Drug Eruptions/etiology , Drug Eruptions/therapy , Humans , Purpura/diagnosis , Purpura/etiology , Purpura/therapy , Skin Diseases/diagnosis , Skin Diseases/therapy , Skin Diseases, Infectious/diagnosis , Skin Diseases, Infectious/etiology , Skin Diseases, Infectious/therapy , Steroids/adverse effects , Sunburn/diagnosis , Sunburn/etiology , Sunburn/therapy
13.
Pediatr Dermatol ; 30(6): e278-80, 2013.
Article in English | MEDLINE | ID: mdl-22471786

ABSTRACT

Hermansky-Pudlak syndrome (HPS) is a rare autosomal-recessive disorder characterized by oculocutaneous albinism, a hemorrhagic diathesis due to platelet dysfunction, and lysosomal ceroid accumulation that can cause a Crohn's-like granulomatous colitis and pulmonary fibrosis. We report peristomal and vulvar cutaneous involvement of the granulomatous colitis in HPS.


Subject(s)
Crohn Disease/etiology , Crohn Disease/pathology , Hermanski-Pudlak Syndrome/complications , Hermanski-Pudlak Syndrome/pathology , Skin Ulcer/etiology , Skin Ulcer/pathology , Biopsy , Child , Female , Humans , Skin/pathology , Vulva/pathology
16.
Sports Med ; 41(11): 967-84, 2011 Nov 01.
Article in English | MEDLINE | ID: mdl-21985216

ABSTRACT

Participation in ice-skating sports, particularly figure skating, ice hockey and speed skating, has increased in recent years. Competitive athletes in these sports experience a range of dermatological injuries related to mechanical factors: exposure to cold temperatures, infectious agents and inflammation. Part I of this two part review discussed the mechanical dermatoses affecting ice-skating athletes that result from friction, pressure, and chronic irritation related to athletic equipment and contact with surfaces. Here, in Part II, we review the cold-induced, infectious and inflammatory skin conditions observed in ice-skating athletes. Cold-induced dermatoses experienced by ice-skating athletes result from specific physiological effects of cold exposure on the skin. These conditions include physiological livedo reticularis, chilblains (pernio), Raynaud phenomenon, cold panniculitis, frostnip and frostbite. Frostbite, that is the literal freezing of tissue, occurs with specific symptoms that progress in a stepwise fashion, starting with frostnip. Treatment involves gradual forms of rewarming and the use of friction massages and pain medications as needed. Calcium channel blockers, including nifedipine, are the mainstay of pharmacological therapy for the major nonfreezing cold-induced dermatoses including chilblains and Raynaud phenomenon. Raynaud phenomenon, a vasculopathy involving recurrent vasospasm of the fingers and toes in response to cold, is especially common in figure skaters. Protective clothing and insulation, avoidance of smoking and vasoconstrictive medications, maintaining a dry environment around the skin, cold avoidance when possible as well as certain physical manoeuvres that promote vasodilation are useful preventative measures. Infectious conditions most often seen in ice-skating athletes include tinea pedis, onychomycosis, pitted keratolysis, warts and folliculitis. Awareness, prompt treatment and the use of preventative measures are particularly important in managing such dermatoses that are easily spread from person to person in training facilities. The use of well ventilated footgear and synthetic substances to keep feet dry, as well as wearing sandals in shared facilities and maintaining good personal hygiene are very helpful in preventing transmission. Inflammatory conditions that may be seen in ice-skating athletes include allergic contact dermatitis, palmoplantar eccrine hidradenitis, exercise-induced purpuric eruptions and urticaria. Several materials commonly used in ice hockey and figure skating cause contact dermatitis. Identification of the allergen is essential and patch testing may be required. Exercise-induced purpuric eruptions often occur after exercise, are rarely indicative of a chronic venous disorder or other haematological abnormality and the lesions typically resolve spontaneously. The subtypes of urticaria most commonly seen in athletes are acute forms induced by physical stimuli, such as exercise, temperature, sunlight, water or particular levels of external pressure. Cholinergic urticaria is the most common type of physical urticaria seen in athletes aged 30 years and under. Occasionally, skaters may develop eating disorders and other related behaviours some of which have skin manifestations that are discussed herein. We hope that this comprehensive review will aid sports medicine practitioners, dermatologists and other physicians in the diagnosis and treatment of these dermatoses.


Subject(s)
Cold Temperature , Hockey/injuries , Skating/injuries , Skin Diseases/etiology , Deficiency Diseases/complications , Feeding and Eating Disorders/complications , Humans , Skin Diseases/diagnosis , Skin Diseases/therapy , Skin Diseases, Infectious/etiology , Sports Equipment , Sports Medicine
17.
Dermatol Online J ; 17(10): 8, 2011 Oct 15.
Article in English | MEDLINE | ID: mdl-22031634

ABSTRACT

A six-week-old girl presented with a segmental, focally atrophic, vascular patch in the diaper area, present since birth. It had undergone minimal proliferation, but had ulcerated. Evaluation to rule out LUMBAR (Lower body hemangioma/Lipoma or other cutaneous anomalies, Urogenital anomalies, Myelopathy, Bony deformities, Anorectal/Arterial anomalies, and Renal anomalies) syndrome, which included ultrasound and Doppler examination of the abdomen, spine, and pelvis, was negative. We report a unique case of an ulcerated, segmental abortive hemangioma of the anogenital area with excellent clinical response to topical timolol gel.


Subject(s)
Hemangioma/congenital , Perineum/pathology , Skin Neoplasms/congenital , Administration, Cutaneous , Adrenergic beta-Antagonists/administration & dosage , Adrenergic beta-Antagonists/therapeutic use , Biomarkers, Tumor/analysis , Female , Glucose Transporter Type 1/analysis , Hemangioma/chemistry , Hemangioma/complications , Hemangioma/drug therapy , Hemangioma/pathology , Humans , Infant , Skin Neoplasms/chemistry , Skin Neoplasms/complications , Skin Neoplasms/drug therapy , Skin Neoplasms/pathology , Skin Ulcer/etiology , Timolol/administration & dosage , Timolol/therapeutic use
19.
Sports Med ; 41(9): 709-19, 2011 Sep 01.
Article in English | MEDLINE | ID: mdl-21846161

ABSTRACT

Figure skaters, ice-hockey players and speed skaters experience a range of dermatologic conditions and tissue-related injuries on account of mechanical trauma, infectious pathogens, inflammatory processes and environmental factors related to these competitive pursuits. Sports medicine practitioners, family physicians, dermatologists and coaches should be familiar with these skin conditions to ensure timely and accurate diagnosis and management of affected athletes. This review is Part I of a subsequent companion review and provides a comprehensive review of mechanical dermatoses experienced by ice-skating athletes, including skater's nodules and its variants, pump bumps, piezogenic pedal papules, talon noir, skate/lace bite, friction bullae, corns and calluses, onychocryptosis, skater's toe and skate blade-induced lacerations. These injuries result from friction, shear forces, chronic pressure and collisions with surfaces that occur when athletes endure repetitive jump landings, accelerated starts and stops and other manoeuvres during rigorous training and competition. Ill-fitting skates, improper lacing techniques and insufficient lubrication or protective padding of the foot and ankle often contribute to the development of skin conditions that result from these physical and mechanical stresses. As we will explain, simple measures can frequently prevent the development of these conditions. The treatment of skater's nodules involves reduction in chronic stimulation of the malleoli, and the use of keratolytics and intralesional steroid injections; if malleolar bursitis develops, bursa aspirations may be required. Pump bumps, which result from repetitive friction posteriorly, can be prevented by wearing skates that fit correctly at the heel. Piezogenic pedal papules may be treated conservatively by using heel cups, compressive stockings and by reducing prolonged standing. Talon noir usually resolves without intervention within several weeks. The treatment of skate bite is centred on reducing compression by the skate tongue of the extensor tendons of the anterior ankle, which can be accomplished by use of proper lacing techniques, increasing pliability of the skate tongue and using protective padding, such as Bunga Pads™. Anti-inflammatory medications and cold compresses can also help reduce inflammation. Friction bullae are best managed by careful lancing of painful blisters and application of petrolatum or protective dressings to accelerate healing; preventative measures include the use of well fitting skates, proper lacing techniques and moisture-wicking socks. Corns and calluses are similarly best prevented by the use of well fitted skates and orthotic devices. Symptomatic, debridement reduces the irritant effect of the thick epidermis, and can be accomplished by soaking the area in warm water followed by paring. Application of creams with high concentrations of urea or salicylic acid can also soften callosities. Cases of onychocryptosis benefit from warm soaks, antibiotic ointments and topical steroids to reduce inflammation, but sometimes chemical or surgical matricectomies are required. Preventative measures of both onychocryptosis and skater's toe include cutting toenails straight across to allow for a more equal distribution of forces within the toe box. Finally, the prevention and treatment of lacerations, which constitute a potentially fatal type of mechanical injury, require special protective gear and acute surgical intervention with appropriate suturing. The subsequent companion review of skin conditions in ice skaters will discuss infectious, inflammatory and cold-induced dermatoses, with continued emphasis on clinical presentation, diagnosis, treatment and prevention.


Subject(s)
Hockey/injuries , Skating/injuries , Skin Diseases/diagnosis , Skin Diseases/therapy , Athletes , Callosities/diagnosis , Callosities/etiology , Callosities/therapy , Female , Humans , Lacerations/diagnosis , Lacerations/etiology , Lacerations/therapy , Male , Skin Diseases/etiology , Stress, Mechanical
SELECTION OF CITATIONS
SEARCH DETAIL
...